Page last updated: 2024-12-05

protoverin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Protoveratrines: Mixtures of closely related hypotensive alkaloids from Veratrum album (Liliaceae). They have been used in the treatment of hypertension but have largely been replaced by drugs with fewer adverse effects. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID408888
MeSH IDM0017919

Synonyms (16)

Synonym
protoveratrine a and b
NSC16650 ,
8053-18-7
protoveratrine (a + b)
protoveratrine a, mixt. with protoveratrine b
provell
protoveratrines a and b
veralba
nsc-16650
protoveratrines
tensatrin
nsc 16650
unii-w9bc83co03
pvs-295
w9bc83co03 ,
ebrantan

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves for synaptosomal 22Na uptake and for the inotropic effect on guinea pig left atria are parallel for sulmazole and the quinazolone drug, with first an increase and then a decrease in activity."( Effect of some new cardiotonic agents on synaptosomal sodium uptake.
Decker, N; Grima, M; Schwartz, J, 1986
)
0.27
" Protoveratrine A increased the uptake of 22Na+ into the slices with a similar dose-response curve to that found for gamma-aminobutyrate release."( The role of Ca2+ in the protoveratrine-induced release of gamma-aminobutyrate from rat brain slices.
Minchin, MC, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (183)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990178 (97.27)18.7374
1990's4 (2.19)18.2507
2000's1 (0.55)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (1.58%)6.00%
Case Studies1 (0.53%)4.05%
Observational0 (0.00%)0.25%
Other186 (97.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]